 Cell Transformation, Neoplastic
"Cell Transformation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Descriptor ID |
D002471
|
| MeSH Number(s) |
C04.697.098.500 C23.550.727.098.500
|
| Concept/Terms |
Cell Transformation, Neoplastic- Cell Transformation, Neoplastic
- Tumorigenic Transformation
- Transformation, Tumorigenic
- Transformations, Tumorigenic
- Tumorigenic Transformations
- Transformation, Neoplastic Cell
- Neoplastic Cell Transformation
- Cell Transformations, Neoplastic
- Neoplastic Cell Transformations
- Transformations, Neoplastic Cell
- Neoplastic Transformation, Cell
- Cell Neoplastic Transformation
- Cell Neoplastic Transformations
- Neoplastic Transformations, Cell
- Transformation, Cell Neoplastic
- Transformations, Cell Neoplastic
|
Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Neoplastic".
This graph shows the total number of publications written about "Cell Transformation, Neoplastic" by people in this website by year, and whether "Cell Transformation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 3 | 0 | 3 | | 1993 | 2 | 0 | 2 | | 1994 | 3 | 0 | 3 | | 1995 | 3 | 1 | 4 | | 1996 | 3 | 0 | 3 | | 1997 | 1 | 1 | 2 | | 1998 | 2 | 3 | 5 | | 1999 | 1 | 4 | 5 | | 2000 | 4 | 4 | 8 | | 2001 | 2 | 1 | 3 | | 2002 | 6 | 3 | 9 | | 2003 | 2 | 2 | 4 | | 2004 | 9 | 6 | 15 | | 2005 | 4 | 4 | 8 | | 2006 | 6 | 8 | 14 | | 2007 | 7 | 6 | 13 | | 2008 | 7 | 3 | 10 | | 2009 | 8 | 3 | 11 | | 2010 | 5 | 4 | 9 | | 2011 | 3 | 9 | 12 | | 2012 | 7 | 6 | 13 | | 2013 | 6 | 6 | 12 | | 2014 | 4 | 6 | 10 | | 2015 | 8 | 5 | 13 | | 2016 | 5 | 5 | 10 | | 2017 | 4 | 4 | 8 | | 2018 | 6 | 3 | 9 | | 2019 | 5 | 3 | 8 | | 2020 | 3 | 2 | 5 | | 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Transformation, Neoplastic" by people in Profiles.
-
Klein BJ, Deshpande A, Cox KL, Xuan F, Zandian M, Barbosa K, Khanal S, Tong Q, Zhang Y, Zhang P, Sinha A, Bohlander SK, Shi X, Wen H, Poirier MG, Deshpande AJ, Kutateladze TG. The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations. Nat Commun. 2021 07 05; 12(1):4130.
-
Rogawski DS, Deng J, Li H, Miao H, Borkin D, Purohit T, Song J, Chase J, Li S, Ndoj J, Klossowski S, Kim E, Mao F, Zhou B, Ropa J, Krotoska MZ, Jin Z, Ernst P, Feng X, Huang G, Nishioka K, Kelly S, He M, Wen B, Sun D, Muntean A, Dou Y, Maillard I, Cierpicki T, Grembecka J. Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity. Nat Commun. 2021 05 14; 12(1):2792.
-
Jackson DN, Alula KM, Delgado-Deida Y, Tabti R, Turner K, Wang X, Venuprasad K, Souza RF, Désaubry L, Theiss AL. The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/ß-Catenin Signaling. Cancer Res. 2020 09 01; 80(17):3519-3529.
-
Kar A, Wierman ME, Kiseljak-Vassiliades K. Update on in-vivo preclinical research models in adrenocortical carcinoma. Curr Opin Endocrinol Diabetes Obes. 2020 06; 27(3):170-176.
-
Liu H, Lee S, Zhang Q, Chen Z, Zhang G. The potential underlying mechanism of the leukemia caused by MLL-fusion and potential treatments. Mol Carcinog. 2020 07; 59(7):839-851.
-
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, V Tresckow J, Lange E, Kiehl M, Dreyling M, Ritgen M, Dürig J, Tausch E, Schneider C, Stilgenbauer S, Wendtner CM, Fischer K, Hallek M, Eichhorst B. Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. Leukemia. 2021 01; 35(1):169-176.
-
Chen SMY, Krinsky AL, Woolaver RA, Wang X, Chen Z, Wang JH. Tumor immune microenvironment in head and neck cancers. Mol Carcinog. 2020 07; 59(7):766-774.
-
Towers CG, Wodetzki D, Thorburn A. Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations. J Cell Biol. 2020 01 06; 219(1).
-
Leach SM, Finigan J, Vasu VT, Mishra R, Ghosh M, Foster D, Mason R, Kosmider B, Farias Hesson E, Kern JA. The Kinome of Human Alveolar Type II and Basal Cells, and Its Reprogramming in Lung Cancer. Am J Respir Cell Mol Biol. 2019 10; 61(4):481-491.
-
Fan X, Bjerke GA, Riemondy K, Wang L, Yi R. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model. Mol Carcinog. 2019 12; 58(12):2241-2253.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|